The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. Novartis raised its full-year outlook for a second quarter in a row on Tuesday due to the ongoing absence of generic competition to its best-selling blood pressure pill Diovan. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: DRUGS SOCIETY BUSINESS LOGO) - RTX14J87